METHODS: Retrospective analysis of insulinomas diagnosed in Tampere University Hospital. RESULTS: We found 23 iNET cases corresponding to an incidence of 0.7/million/year. All had neuroglycopenic symptoms and 83% had autonomic ones. The median diagnostic delay (from first symptoms up to diagnosis) was 25 months. Preoperative imaging found the tumor in 87%. Twenty-one out of 22 patients who underwent surgery recovered completely. CONCLUSIONS: Despite improved imaging the diagnostic delay of iNETs remained unchanged. Hypoglycemia and insulinoma should be considered as a cause of unspecific, symptomatic attacks
Department of Surgery no. 2, scientific research laboratory "Reconstructive surgery of the digestive...
We describe the first patient diagnosed with an insulinoma in Oman and successfully managed with a d...
Abstract Background Malignant insulinoma is extremely rare and accounts for only 10% of total insuli...
Objective. Insulinomas are rare pancreatic tumours. Population-based data on their incidence, clinic...
Abstract Objective: Insulinomas are rare pancreatic tumours. Population-based data on their inciden...
Objective. Insulinomas are rare pancreatic tumours. Population-based data on their incidence, clinic...
Background/Aim. Insulinomas are rare benign tumors in the most cases and the most frequent endocr...
Background: Hypoglycemic manifestations are highly variable in patients with an insulinoma and large...
Insulinoma is a rare neuroendocrine tumor, occurring almost exclusively in the pancreas. Most often ...
Introduction: Insulinomas are rare pancreatic neuroendocrine tumors derived from beta cells responsi...
Aida Taye, Steven K Libutti Department of Surgery, Montefiore Medical Center/Albert Einstein, Colleg...
Background: Insulinomas are rare pancreatic endocrine tumors. Most are benign and solitary. However,...
Insulinomas are rare tumors, accounting for 1-2% of all neoplasms of the pancreas. Usually their tre...
Objective: To review patients records operated with the diagnosis of insulinoma and to discuss their...
Insulinoma is the most common pancreatic islet cell tumor, usually presenting with symptoms of neuro...
Department of Surgery no. 2, scientific research laboratory "Reconstructive surgery of the digestive...
We describe the first patient diagnosed with an insulinoma in Oman and successfully managed with a d...
Abstract Background Malignant insulinoma is extremely rare and accounts for only 10% of total insuli...
Objective. Insulinomas are rare pancreatic tumours. Population-based data on their incidence, clinic...
Abstract Objective: Insulinomas are rare pancreatic tumours. Population-based data on their inciden...
Objective. Insulinomas are rare pancreatic tumours. Population-based data on their incidence, clinic...
Background/Aim. Insulinomas are rare benign tumors in the most cases and the most frequent endocr...
Background: Hypoglycemic manifestations are highly variable in patients with an insulinoma and large...
Insulinoma is a rare neuroendocrine tumor, occurring almost exclusively in the pancreas. Most often ...
Introduction: Insulinomas are rare pancreatic neuroendocrine tumors derived from beta cells responsi...
Aida Taye, Steven K Libutti Department of Surgery, Montefiore Medical Center/Albert Einstein, Colleg...
Background: Insulinomas are rare pancreatic endocrine tumors. Most are benign and solitary. However,...
Insulinomas are rare tumors, accounting for 1-2% of all neoplasms of the pancreas. Usually their tre...
Objective: To review patients records operated with the diagnosis of insulinoma and to discuss their...
Insulinoma is the most common pancreatic islet cell tumor, usually presenting with symptoms of neuro...
Department of Surgery no. 2, scientific research laboratory "Reconstructive surgery of the digestive...
We describe the first patient diagnosed with an insulinoma in Oman and successfully managed with a d...
Abstract Background Malignant insulinoma is extremely rare and accounts for only 10% of total insuli...